Subscribe to Newsletter
Business & Profession Other

Aflibercept and the Evolution of CRVO Management

Articles:

A brief history of CRVO and the treatment options
Andrew Lotery, Honorary Consultant Ophthalmologist at the University Hospital Southampton and Professor of Ophthalmology at the University of Southampton.

Aflibercept:leveraging efficacy and the window of opportunity
Bora Eldem, Hacettepe University Hospital, Ankara, Turkey.

Beyond clinical trials: the proactive treatand- extend approach
Anat Loewenstein, Tel Aviv Medical Center & Sackler Faculty of Medicine, University of Tel Aviv, Israel.

Treat-and-extend in the clinic: case study review
Stephan Michels, City Hospital Triemli, Zurich, Switzerland.

 

Download the pdf here

 

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: